ÂÜÀòÂÒÂ×

Marta Schumacher has a diverse and extensive work experience in the field of clinical operations. Marta has held various senior roles in different companies, showcasing their strategic planning, oversight, and execution abilities in clinical trials.

From 2019 onwards, Marta served as the Senior Director of Global Clinical Operations at Annexon Biosciences. Here, they implemented improvements such as eTMF and QDS in their global clinical trials for neurodegenerative disorders.

Prior to that, Marta worked at BioPharmX as the Vice President of Clinical Operations from 2017 to 2019. During their tenure, they were responsible for strategic planning, clinical trial execution, and oversight of CROs and clinical support staff.

From 2014 to 2017, Marta was the Senior Director of Clinical Operations at Versartis, Inc. Here, they contributed to strategic planning, successfully completed a Japanese Phase 2/3 study, and implemented process improvements in various areas.

Before that, Marta worked as the Country Study Manager (consultant) at Genentech for a brief period in 2014 and as the Senior Director at InClin, Inc from 2011 to 2014. At InClin, they provided project management expertise for various clients and managed the execution of multiple clinical trials.

From 2008 to 2011, Marta served as the Clinical Operations Leader at Roche SSF/Palo Alto. In this role, they managed study team members, contributed to clinical plans, and maintained relationships with key opinion leaders and CROs.

Prior to that, Marta held the position of Senior Clinical Research Associate/Pharmacology Study Manager at Roche Palo Alto from 2004 to 2007 and worked as a Senior Director (Consultant) at BN-ImmunoTherapeutics from 2005 to 2007.

Furthermore, they worked as a Senior Clinical Research Associate at Corgentech, SSF from 2003 to 2004, managing a Phase III Peripheral Vascular study.

Marta began their career as a Senior Clinical Research Associate at Roche Bioscience from 1999 to 2003.

Overall, Marta Schumacher's work experience highlights their expertise in clinical operations, strategic planning, and successful completion of clinical trials.

Marta Schumacher pursued their education from 1978 to 1983. During this period, they obtained a Master of Business Administration (MBA) degree in Information Systems Management from Golden Gate University. Additionally, they also completed their Bachelor of Arts (BA) degree in Genetics from the University of California, Berkeley.